Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP601403.RAFfheyqpZcm6ynOXpHyN5wv5fePMO6NRN5MQUD2yDRHs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP601403.RAFfheyqpZcm6ynOXpHyN5wv5fePMO6NRN5MQUD2yDRHs130_assertion type Assertion NP601403.RAFfheyqpZcm6ynOXpHyN5wv5fePMO6NRN5MQUD2yDRHs130_head.
- NP601403.RAFfheyqpZcm6ynOXpHyN5wv5fePMO6NRN5MQUD2yDRHs130_assertion description "[Resected pancreatic ductal and ampullary adenocarcinomas (n = 50) were analyzed for loss of heterozygosity (LOH) at 15 markers including 5q(APC), 6q(TBSP2), 9p(p16), 10q(PTEN), 12q(MDM2), 17p(TP53), and 18q(DCC/SMAD4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP601403.RAFfheyqpZcm6ynOXpHyN5wv5fePMO6NRN5MQUD2yDRHs130_provenance.
- NP601403.RAFfheyqpZcm6ynOXpHyN5wv5fePMO6NRN5MQUD2yDRHs130_assertion evidence source_evidence_literature NP601403.RAFfheyqpZcm6ynOXpHyN5wv5fePMO6NRN5MQUD2yDRHs130_provenance.
- NP601403.RAFfheyqpZcm6ynOXpHyN5wv5fePMO6NRN5MQUD2yDRHs130_assertion SIO_000772 18677542 NP601403.RAFfheyqpZcm6ynOXpHyN5wv5fePMO6NRN5MQUD2yDRHs130_provenance.
- NP601403.RAFfheyqpZcm6ynOXpHyN5wv5fePMO6NRN5MQUD2yDRHs130_assertion wasDerivedFrom befree-20140225 NP601403.RAFfheyqpZcm6ynOXpHyN5wv5fePMO6NRN5MQUD2yDRHs130_provenance.
- NP601403.RAFfheyqpZcm6ynOXpHyN5wv5fePMO6NRN5MQUD2yDRHs130_assertion wasGeneratedBy ECO_0000203 NP601403.RAFfheyqpZcm6ynOXpHyN5wv5fePMO6NRN5MQUD2yDRHs130_provenance.